White Paper: Moving CGTx Clinical Development Forward in 2023
Clinical trials are foundational to developing innovative, life-saving treatments and cures for patients. For developers of cell and gene therapy (CGTx) products, the path to clinical success is fraught with vast and complex challenges. The CGTx field is becoming more crowded, with increased clinical trial volume and an influx of less-experienced sponsors contributing to an increase in clinical holds in the category. Such challenges intensify the pressure to succeed in a fiercely competitive environment.
White Paper: Market Trends and Expectations for Advanced Therapies in 2023
The cell and gene therapy space has undergone transformational change in the last few years, driven by the promise these modalities have demonstrated in addressing rare and intractable diseases. Achievements in the CAR-T therapy space – there are now six approved CAR-T treatments on the market – in conjunction with breakthroughs in gene therapy and viral vector drugs, have signaled a new era of innovation aimed at furthering cell and gene therapies within the greater healthcare landscape.
Conference: 3rd Gene and Cell Therapies: CMC, CGT & Vector Manufacturing Summit
Precision will be at this year’s 3rd Gene and Cell Therapies: CMC, CGT & Vector Manufacturing Summit, June 20-21, 2023, in Vienna, Austria. Connect with our team of experts as they lead meaningful presentations and discussions throughout this event providing insights into the development for cell and gene therapies.
Connect with our Advanced Therapy experts!
- Schedule a meeting with one our our experts
- Be sure to attend Precision’s own, Houria Bachtarzi’s presentation on June 20, 2023, at 10:10 AM CEST
You can register for the 3rd Gene and Cell Therapies: CMC, CGT & Vector Manufacturing Summit below:
On-Demand: Cell & Gene Day, 2023
Even as cell and gene therapies inspire hope for patients who previously had none, the path to commercialization is littered with roadblocks. There is a pressing need for increased efficiency, enhanced safety, and innovative approach to pricing and access. How are leading CGTx innovators approaching these challenges? Find out at Cell & Gene Day 2023, a free virtual event, streaming on demand HERE.
Precision for Medicine Receives Multiple CRO Awards
Precision for Medicine, a leading biomarker-driven clinical research organization (CRO), received wide recognition at the prestigious 2023 CRO Leadership Awards. The awards acknowledge top CRO partners and are determined by feedback from pharma and biotech sponsors. Precision has been honored in all five categories: Capabilities, Compatibility, Expertise, Quality, and Reliability, securing awards in the Overall, Big Pharma, and Small Pharma categories, along with several distinguished Champion Awards.
This recognition serves as a testament to our commitment to quality and our clients’ trust in delivering measurable results.